Conference Highlights of the 2022 Genitourinary Cancers Symposium *

February 17-19, 2022; San Francisco, California
Review an expert conference preview commentary, a summary highlights slideset, and expert analysis of key studies from the 2022 Genitourinary Cancers Symposium.

Share

Program Content

Activities

ASCO GU 2022 Highlights
Key Studies in Urothelial, Prostate, and Kidney Cancer: CCO Independent Conference Highlights of the 2022 Genitourinary Cancers Symposium
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 18, 2022

Expires: April 17, 2023

Activities

ASCO GU 2022: Key Studies
An Expert’s Guide to Key Studies at the 2022 ASCO Genitourinary Cancers Symposium
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: February 15, 2022

Expires: February 14, 2023

Activities

ASCO GU 2022 Highlights
CCO Conference Highlights of ASCO GU 2022
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2022

Expires: February 27, 2023

Faculty

cover img faculity

Toni K. Choueiri, MD

Director, Lank Center for Genitourinary Oncology
Medical Director, International Strategic Initiatives
Dana-Farber Cancer Institute
Co-Leader, Kidney Cancer Program
Dana-Farber/Harvard Cancer Center
Jerome and Nancy Kohlberg Professor of Medicine
Harvard Medical School
Boston, Massachusetts 

cover img faculity

Daniel P. Petrylak, MD

Professor of Medicine
Smilow Cancer Center
Yale University Medical Center
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bayer Healthcare Pharma

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

Seagen and Astellas

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.